Outcomes of bevacizumab combined with chemotherapy in lung adenocarcinoma‐induced malignant pleural effusion

BACKGROUND: VEGF is critical in the pathogenesis of malignant pleural effusion (MPE). To understand the clinical benefits of antiangiogenic agents, the efficacy of chemotherapy containing bevacizmab was investigated in patients with lung adenocarcinoma‐induced MPE. METHODS: The data of lung adenocar...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Hong, Meng, Qiyi, Li, Mingzhi, Shi, Liang, Tang, Junfang, Liu, Zhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792722/
https://www.ncbi.nlm.nih.gov/pubmed/29297985
http://dx.doi.org/10.1111/1759-7714.12582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792722/
https://www.ncbi.nlm.nih.gov/pubmed/29297985
http://dx.doi.org/10.1111/1759-7714.12582

Ejemplares similares